This blog post will explain the changes we are making to the primer scheme naming in
wf-artic due to underlying changes in the ONT Midnight SARS-CoV-2 sequencing kit. We will also describe a new feature of
wf-artic allowing specification of custom primer schemes.
Tiled amplicon sequencing allows us to cover small genomes with short slightly overlapping PCR amplicons. This approach has a number of advantages, possibly the most important being that we can still recover full or nearly full genomes from samples with a low viral load or degraded RNA.
To achieve this tiled amplicon sequencing approach, pools of primer pairs are used to create the amplicons that cover the whole of the genome. For SARS-CoV-2 we analyse this data using the Network Artic FieldBioinformatics tool using
wf-artic. This tool requires a bed file of the primer locations used in the assay. These primer “schemes” provide the start and end position of each primer but do not include the primer sequences as these are not required by the workflow.
The primer scheme bed files are required for a couple of reasons:
wf-artic workflow included a single Midnight primer scheme called
V1200. Previous additions of primers to ONT Midnight have been sequence only changes and have therefore required no changes to the primer scheme. Version 3 of the ONT Midnight kit adds a new primer to tackle the drop out of amplicon 21 as a result of a 9bp deletion in this region in BA.2 samples. This requires a new scheme. We are therefore, after consulting members of the community, renaming our Midnight schemes to be in line with our physical kit versions.
We are making it clearer in the
wf-artic repository which scheme should be used with each physical assay in addition to making versioning for Midnight schemes more transparent.
The schemes now included in
So when running ARTIC or
wf-artic we specify the version as
<ASSAY>/<VERSION> where assay could be, for example
Midnight-ONT and the version could be
V2, this would be written as
The rule of thumb for Midnight kits bought from ONT is that the kit version will always pair with the scheme version e.g.
EXP-MRT001.30 should be paired with primer scheme
Midnight-ONT/V3. If you use the V2 Midnight primers from IDT then you would use
Midnight-IDT/V2 as the scheme name.
The table shows the additional (i.e. original V1&V2 primers remain in the mix) primers added to Midnight-ONT kit V3 to address BA.2 amplicon 21 drop-out and provide general performance improvements.
|Primer||Start V1&V2||End V1&V2||Sequence V1&V2||Start V3||End V3||Sequence V3|
While the additional 22R, 23L and 24L primers represent single base changes (lowercase), 21R has been redesigned to deal with a 9bp deletion found in the primer region in BA.2.
The improvements are clear on a BA.2 sample of ct 20 sequenced using Midnight V2 and Midnight V3:
To account for the addition of a primer 21R with a different position we decided to use a scheme containing a single entry for 21R but expand this primer region to cover the whole of the additional new 21R and the original 21R primer. If you use an older version of the scheme it could affect your analysis, 7 bases that could result from primers might be included in your final consensus so you should update your workflows.
It is advisable to update to the latest version of
wf-artic when you start using the new kit version.
The growing number of supported schemes mean that we needed to reorganise the
primer_schemes folder. The new structure is shown below. Briefly, under each scheme name of
spike-seq a folder exists that separates the schemes into the main assays, be that
Midnight-ONT, or the newly added
Midnight-IDT. Within each of these folders are the primer versions available for that assay. The scheme name therefore remains
SARS-CoV-2, but the version now includes the assay and version of that assay, e.g
data/primer_schemes├── SARS-CoV-2│ ├── ARTIC│ │ ├── V1│ │ │ ├── SARS-CoV-2.reference.fasta│ │ │ └── SARS-CoV-2.scheme.bed│ │ ├── V2│ │ │ ├── SARS-CoV-2.reference.fasta│ │ │ └── SARS-CoV-2.scheme.bed│ │ ├── V3│ │ │ ├── SARS-CoV-2.reference.fasta│ │ │ └── SARS-CoV-2.scheme.bed│ │ ├── V4│ │ │ ├── SARS-CoV-2.reference.fasta│ │ │ └── SARS-CoV-2.scheme.bed│ │ └── V4.1│ │ ├── SARS-CoV-2.reference.fasta│ │ └── SARS-CoV-2.scheme.bed│ ├── Midnight-IDT│ │ └── V1│ │ ├── SARS-CoV-2.reference.fasta│ │ └── SARS-CoV-2.scheme.bed│ ├── Midnight-ONT│ │ ├── V1│ │ │ ├── SARS-CoV-2.reference.fasta│ │ │ └── SARS-CoV-2.scheme.bed│ │ ├── V2│ │ │ ├── SARS-CoV-2.reference.fasta│ │ │ └── SARS-CoV-2.scheme.bed│ │ └── V3│ │ ├── SARS-CoV-2.reference.fasta│ │ └── SARS-CoV-2.scheme.bed│ └── NEB-VarSkip